CFH/Fib3 binding may be just one link in a complex chain of events that progresses towards RPE pathology, photoreceptor death and blindness in some forms of AMD, but it offers the interesting possibility of a new target for therapeutic intervention that could perhaps slow the progression of this major cause of vision loss in the aging human population. This evidence concerns the gene CFH and age-related macular degeneration.